s6y

Nuvation Bio Inc.

Ticker
NUVB
CIK
1811063
Industry
Pharmaceutical Preparations
Formerly
Panacea Acquisition Corp

Financials 28

  1. 10-Q Quarterly Report for period ending Sep 30, 2026
  2. 10-Q Quarterly Report for period ending Jun 30, 2026
  3. 10-Q Quarterly Report for period ending Mar 31, 2026
  4. 10-K Annual Report for period ending Dec 31, 2025
  5. 10-Q Quarterly Report for period ending Sep 30, 2025
  6. 10-Q Quarterly Report for period ending Jun 30, 2025
  7. 10-Q Quarterly Report for period ending Mar 31, 2025
  8. 10-K Annual Report for period ending Dec 31, 2024
  9. 10-Q Quarterly Report for period ending Sep 30, 2024
  10. 10-Q Quarterly Report for period ending Jun 30, 2024

All 28 financials filings

News 62

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 62 news filings

Ownership 207

  1. 4 Statement of changes in beneficial ownership of securities
  2. 4 Statement of changes in beneficial ownership of securities
  3. 4 Statement of changes in beneficial ownership of securities
  4. 4 Statement of changes in beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 4 Statement of changes in beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 4 Statement of changes in beneficial ownership of securities
  9. 4 Statement of changes in beneficial ownership of securities
  10. 4/A Statement of changes in beneficial ownership of securities

All 207 ownership filings

Prospectus 38

  1. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  2. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  3. 424B5 Prospectus filed pursuant to Rule 424(b)(5)
  4. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  5. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  6. S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
  7. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  8. S-3 Registration statement for specified transactions by certain issuers
  9. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 38 prospectus filings

Proxies 10

  1. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  2. DEF 14A Definitive proxy statements
  3. DEF 14A Definitive proxy statements
  4. DEFR14A Definitive revised proxy soliciting materials
  5. DEF 14A Definitive proxy statements
  6. PRER14A Preliminary revised proxy soliciting materials
  7. PRER14A Preliminary revised proxy soliciting materials
  8. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

Other 55

  1. 144 Filing for proposed sale of securities under Rule 144
  2. 305B2 Application for designation of a new trustee under the Trust Indenture Act
  3. 144 Filing for proposed sale of securities under Rule 144
  4. 144 Filing for proposed sale of securities under Rule 144
  5. 144 Filing for proposed sale of securities under Rule 144
  6. 144 Filing for proposed sale of securities under Rule 144
  7. 144 Filing for proposed sale of securities under Rule 144
  8. ARS Annual report to security holders
  9. 144 Filing for proposed sale of securities under Rule 144
  10. 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities

All 55 other filings